L Li
Key Laboratory Of Early Prevention And Treatment For Regional High Frequency Tumor, Ministry Of Education
Nanning, 530021, China
Nanning, 530021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Bioinformatics and clinical analysis of CETN2's impact on platinum resistance and prognosis in epithelial ovarian cancer.
Journal: Journal of ovarian research
Published: May 20, 2025
The predictive value of PI3K signaling pathway in ovarian cancer prognosis: a meta-analysis.
Journal: European review for medical and pharmacological sciences
Published: June 10, 2024
GSG2 promotes progression of human endometrial cancer by regulating PD-1/PD-L1 expression via PI3K-AKT pathway.
Journal: International immunopharmacology
Published: February 02, 2024
The impact of lymphadenectomy on the survival outcomes of ovarian clear cell carcinoma: A retrospective study of the SEER database and Chinese registry.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: October 23, 2023
Activation of pyroptosis and ferroptosis is involved in radiation-induced intestinal injury in mice.
Activation of pyroptosis and ferroptosis is involved in radiation-induced intestinal injury in mice.
Journal: Biochemical and biophysical research communications
Published: September 16, 2022
High expression of CETN2 is associated with platinum resistance and poor prognosis in epithelial ovarian cancer.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: August 06, 2022
Retraction Note: The significance of the change pattern of serum CA125 level for judging prognosis and diagnosing recurrences of epithelial ovarian cancer.
Journal: Journal of ovarian research
Published: June 30, 2022
Effect of Apatinib Plus Pegylated Liposomal Doxorubicin vs Pegylated Liposomal Doxorubicin Alone on Platinum-Resistant Recurrent Ovarian Cancer: The APPROVE Randomized Clinical Trial.
Journal: JAMA oncology
Published: June 30, 2022
Evaluation of the prognostic value of lymphadenectomy for low-grade serous ovarian cancer: A case-control multicenter retrospective study.
Journal: Translational oncology
Published: April 30, 2022
MiR-320b and miR-320d as Biomarkers to Predict and Participate in the Formation of Platinum Resistance in Ovarian Cancer Patients.
Journal: Frontiers in oncology
Published: February 22, 2022
Observation of the therapeutic effect of apatinib in advanced platinum-resistant recurrent epithelial ovarian cancer.
Journal: Journal of ovarian research
Published: December 06, 2021
Last Updated: 09/26/2026